Sandra Gurrola
Net worth: 40 $ as of 30/06/2026
Net worth: 40 $ as of 30/06/2026
Sandra Gurrola worked as Senior Manager-Financial Reporting at Metabasis Therapeutics, Inc. from 2007 to 2009.
From 2009 to 2021, served as Secretary & Senior Vice President-Finance at NTN Buzztime, Inc. In 2021, held the position of Senior Vice President at eGames.com Holdings LLC.
From 2022 to 2023, worked as Principal Accounting Officer & VP-Finance at Ernexa Therapeutics, Inc. Completed undergraduate education at San Diego State University in 1991.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 07/05/2026 | 6 ( 0% ) | 40 $ | 30/06/2026 |
| Companies | Position | End |
|---|---|---|
| ERNEXA THERAPEUTICS INC. | Director of Finance/CFO | 03/07/2026 |
eGames.com Holdings LLC
eGames.com Holdings LLC Packaged SoftwareTechnology Services Operates as a game publishing business | Director of Finance/CFO | 01/06/2021 |
| NTN BUZZTIME, INC. | Director of Finance/CFO | 01/03/2021 |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
NTN Buzztime, Inc.
NTN Buzztime, Inc. Packaged SoftwareTechnology Services Develops and distributes TV games for restaurants and sports bars | Technology Services |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs | Health Technology |
San Diego State University
San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
eGames.com Holdings LLC
eGames.com Holdings LLC Packaged SoftwareTechnology Services Operates as a game publishing business | Technology Services |
Eterna Therapeutics, Inc.
Eterna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops cytokine-based drugs for the treatment of cancer | Health Technology |
Select your edition
All financial news and data tailored to specific country editions